KIA
BLFS icon

Kopp Investment Advisors’s BioLife Solutions BLFS Stock Holding History

Kopp Investment Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-29,600
Closed -$152K – 60
2018
Q1 		$152K Buy
+29,600
New +$160K 0.15% 64

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return

Kopp Investment Advisors's BLFS Position: Q2 2018 in Review

Kopp Investment Advisors sold out of BioLife Solutions (BLFS) in Q2 2018, closing a stake of 29,600 shares — an estimated $152K sold.

Kopp Investment Advisors first reported a position in BLFS in Q1 2018 and held it in 1 quarter. The position peaked at $152K in Q1 2018. 49 funds tracked by Wall St. Rank hold BLFS as of Q2 2018.

  • Kopp Investment Advisors reported no remaining BioLife Solutions position as of Q2 2018 after selling out during the quarter.
  • Kopp Investment Advisors sold 29,600 BioLife Solutions shares in Q2 2018, an estimated $152K.
  • Kopp Investment Advisors first reported a position in BioLife Solutions in Q1 2018 and held it in 1 quarter.
  • Kopp Investment Advisors's BioLife Solutions position peaked at $152K in Q1 2018.
  • 49 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2018.

Based on Kopp Investment Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.